Rice Michael 4
4 · BIOLIFE SOLUTIONS INC · Filed May 17, 2023
Insider Transaction Report
Form 4
Rice Michael
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2023-05-17$21.04/sh−33,333$701,326→ 421,468 total - Sale
Common Stock
2023-05-15$18.71/sh−190$3,555→ 454,801 total
Footnotes (3)
- [F1]The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock granted on February 8, 2021.
- [F2]The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 09-14-2022.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.18, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.